Skip to main content
Supplement ScienceSupplementScience

Potassium Dosage Guide

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

General Dosage

99mg per supplement dose (FDA regulation); total intake goal 2,600-3,400mg daily from food + supplements

Maximum dose: No established UL from food; supplemental doses >99mg require medical supervision due to hyperkalemia risk

Dosage Recommendations

General recommendation: 99mg per supplement dose (FDA regulation); total intake goal 2,600-3,400mg daily from food + supplements

Timing: With meals to reduce GI irritation; divided doses preferred • Take with food for best absorption.

Dosage by Condition

Blood pressure support
Increase total potassium intake to 3,500-4,700mg daily via foodStrong
Kidney stone prevention
30-60 mEq potassium citrate daily (prescription)Strong
General health
99mg supplemental + potassium-rich dietStrong

Upper limit: No established UL from food; supplemental doses >99mg require medical supervision due to hyperkalemia risk

Timing & Absorption

With meals to reduce GI irritation; divided doses preferred

Best taken with food for optimal absorption.

Full Potassium Guide

References

  1. Meta-analysisAburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP (2013). Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. DOI PubMed
  2. Meta-analysisD'Elia L, Barba G, Cappuccio FP, Strazzullo P (2011). Potassium intake, stroke, and cardiovascular disease: a meta-analysis of prospective studies. Journal of the American College of Cardiology. DOI PubMed
  3. RCTEttinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997). Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Journal of Urology. DOI PubMed
  4. Rokkas T, Ekmektzoglou K, Niv Y, Graham DY (2025). Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker-Based Dual, Triple, and Quadruple Regimens for First-Line Helicobacter pylori Infection Treatment: A Systematic Review and Network Meta-Analysis.. The American journal of gastroenterology. DOI PubMed
  5. Huang N, Xu Y, Liu C, Liu Y, et al. (2025). Novel Potassium Binders in Reduction of Hyperkalemia and Optimization of RAAS Inhibitors Treatment in Patients with Chronic Kidney Disease or Heart Failure: A Systematic Review and Meta-analysis.. Drugs. DOI PubMed
  6. Kanu JE, Soldera J (2024). Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis.. World journal of gastroenterology. DOI PubMed
  7. Wang Y, Dai X, Zhang X (2024). Network Meta-Analysis of Comparing Different Dosages of Potassium-Competitive Acid Blocker With Proton-Pump Inhibitor in Acid-Related Disorders.. Clinical and translational gastroenterology. DOI PubMed
Show 5 more references
  1. Paolillo S, Basile C, Dell'Aversana S, Esposito I, et al. (2024). Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis.. European journal of internal medicine. DOI PubMed
  2. Meta-analysisBehers BJ, Behers BM, Stephenson-Moe CA, Vargas IA, et al. (2024). Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.. Nutrients. DOI PubMed
  3. Ouyang M, Zou S, Cheng Q, Shi X, et al. (2024). Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors for First-Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta-Analysis.. Helicobacter. DOI PubMed
  4. Abuelazm M, Badr A, Turkmani M, Amin MA, et al. (2024). The efficacy and safety of new potassium binders on renin-angiotensin-aldosterone system inhibitor optimization in heart failure patients: a systematic review and meta-analysis.. ESC heart failure. DOI PubMed
  5. ObservationalGan L, Zhao B, Inoue-Choi M, Liao LM, et al. (2024). Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies.. BMC medicine. DOI PubMed